Publications

Access all of DaC-VaP's research publications.

September 2022: Study looking at risk of thrombocytopenic, haemorrhagic, thromboembolic disorders following first, second and booster vaccination doses and testing positive for SARS-CoV-2

August 2022: Study examining at whether a common data model could be used to help pool data from across the four UK nations to investigate the national uptake of COVID-19 vaccines, as well as monitor the frequency of rare adverse events of interest (AEIs), such as CVST and anaphalaxis, that may occur post-vaccination.

May 2022: pre-print in The Lancet examining whether certain demographic and health characteristics increase the risk of someone not receiving their second dose COVID-19 vaccine and/or experiencing adverse COVID-19 outcomes.

March 2022: A pre-print article examining at whether a common data model could be used to help pool data from across the four UK nations to investigate the national uptake of COVID-19 vaccines, as well as monitor the frequency of rare adverse events of interest (AEIs), such as CVST and anaphalaxis, that may occur post-vaccination.

March 2022: Study looks at the vaccine uptake of people who are prescribed psychotropic medications in Northern Ireland.

February 2022: Research looking at the uptake, effectiveness and waning protection of COVID-19 vaccinations in Welsh health care workers from December 2020 to September 2021.

February 2022: Research published in PLOS Medicine uses data from England, Scotland and Wales to look at possible links between having a rare type of blood clot in the brain, and a first dose of two types of COVID-19 vaccine.

December 2021: Research published in the journal of Public Health examines the link between vaccination and the frequency and duration of COVID-19 outbreaks in Northern Ireland’s care homes.

February 2022: Protocol outlining a new study aimed at assessing the uptake rates, effectiveness, and safety of all currently approved COVID-19 vaccines in the UK.

A summary list of DaC-VaP's Scotland publications previously published on the EAVE II website.

January 2023: Study looks how often people experienced anyone of a specific list of adverse events within 7 days following either their first and second dose COVID-19 vaccine.